Market Currents
Cell Therapeutics (CTIC +32%) rockets higher this morning after announcing the initiation of its...
-
Tuesday, September 11, 2012, 10:48 AM ETCell Therapeutics (CTIC +32%) rockets higher this morning after announcing the initiation of its commercial launch of Pixuvri in the European Union. Pixuvri is a drug for the treatment of aggressive non-Hodgkin Lymphoma.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
